MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.210
+0.080 (7.08%)
Jun 18, 2026, 4:00 PM EDT - Market closed
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $129.62 million as of June 18, 2026. Its market cap has decreased by -49.04% in one year.
Market Cap
129.62M
Enterprise Value
40.25M
1-Year Change
-49.04%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $129.62M, a decrease of -85.55%. That is a compound annual growth rate of -32.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 129.62M | -21.61% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 14.96% |
| Jul 30, 2021 | 897.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InfuSystem Holdings | 176.59M |
| Apyx Medical | 176.29M |
| Inogen | 172.46M |
| Hyperfine | 137.99M |
| Quanterix | 135.67M |
| Owlet | 135.15M |
| CVRx, Inc. | 128.17M |
| AVITA Medical | 121.26M |